Johnson and Johnson 2014 Annual Report Download - page 3

Download and view the complete annual report

Please find page 3 of the 2014 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 84

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84

I am often asked what led me to work in
health care and why I chose to spend most
of my career at Johnson & Johnson. From my
first job at Janssen, the flagship company of
our Pharmaceutical segment, to my current
role as the company’s Chairman and CEO
25 years later, the answer always begins
with Our Credo.
A simple yet powerful document penned
by General Robert Wood Johnson, the son of
our founder and our company’s first Chairman,
Our Credo outlines the Company’s commitments
and responsibilities to the people and
communities we touch every day with our
products and services. For more than 70 years
now, it has served as the moral compass of
Johnson & Johnson – ensuring we never lose
sight of our strong values and the important
needs of the many stakeholders we serve.
That’s why I consider Our Credo to be one of the
most visionary statements of corporate purpose
ever written.
Perhaps there’s no better proof of that than the
success Johnson & Johnson achieved in 2014.
We delivered solid financial results, with full-year
2014 sales of $74.3 billion and adjusted net
earnings of $17.1 billion†, while also continuing
to make investments to accelerate growth for
the long term.
And while I am pleased with our performance,
we know that we can never rest, because
providing sustainable high-quality health care
is one of our society’s greatest challenges.
This is an unprecedented era in human history.
The historic aging rate of the world’s population,
along with a growing middle class around the
world, brings dramatically greater demand for
higher quality health care; and governments
and health systems must manage this with
increasingly strained resources.
At Johnson & Johnson, Our Credo compels
us to innovate in areas where there are unmet
medical needs, overcome barriers and advance
THERE IS
NO COMPANY
BETTER
POSITIONED
TO HELP MEET
THESE URGENT
NEEDS THAN
JOHNSON &
JOHNSON
MARCH 2015
TO OUR
SHAREHOLDERS
ALEX GORSKY
Chairman, Board of Directors
and Chief Executive Officer
CHAIRMAN’S LETTER • I